Compound Detail
CHEMBL447664
VIPADENANT 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL447664 |
| Name | VIPADENANT |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | HQSBCDPYXDGTCL-UHFFFAOYSA-N |
4
Targets
14
Activities
2
Assay Types
7
PK Parameters
20
Publications
12
Known Names
1
Indications
1
Mechanisms
Molecular Properties
321.3
MW (Da)
2.00
ALogP
8
HBA
2
HBD
121.7
PSA (Ų)
0.55
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Adenosine A2a receptor antagonist | ANTAGONIST | Adenosine receptor A2a | ✓ | ✓ |
Indications
Parkinson Disease
Activity Summary
Ki 10 meas. best 9.1
Kd 4 meas. best 9.2
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Adenosine receptor A2a CHEMBL251 | Kd | 9.2 | 9.2 | 0.6 | 1 |
| Adenosine receptor A2a CHEMBL251 | Ki | 9.1 | 8.9425 | 0.8 | 4 |
| Adenosine receptor A2b CHEMBL255 | Kd | 7.5 | 7.5 | 31.6 | 1 |
| Adenosine receptor A2b CHEMBL255 | Ki | 7.2 | 7.2 | 63.0 | 2 |
| Adenosine receptor A1 CHEMBL226 | Ki | 7.17 | 7.17 | 68.0 | 2 |
| Adenosine receptor A1 CHEMBL226 | Kd | 7.0 | 7.0 | 100.0 | 1 |
| Adenosine receptor A3 CHEMBL256 | Ki | 6.0 | 6.0 | 1005.0 | 2 |
| Adenosine receptor A3 CHEMBL256 | Kd | 5.8 | 5.8 | 1584.9 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 35.0 | % | Rattus norvegicus |
| KA | 0.58 | nM | Homo sapiens |
| KA | 95.0 | nM | Homo sapiens |
| KA | 31.0 | nM | Homo sapiens |
| KA | 1500.0 | nM | Homo sapiens |
| T1/2 | 2.0 | hr | Rattus norvegicus |
| Tmax | 0.5 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5058564 | Fibroblast | 7 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 5 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 5 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 5 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 5 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 5 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 5 |
| - | 10.6019/CHEMBL5058564 | HEK-293T | 4 |
| 24164628 | 10.1021/jm4011669 | Unchecked | 3 |
| 19072055 | 10.1021/jm800961g | Adenosine receptor A3 | 3 |
| 19072055 | 10.1021/jm800961g | Rattus norvegicus | 3 |
| 19072055 | 10.1021/jm800961g | Adenosine receptor A2a | 3 |
| 19072055 | 10.1021/jm800961g | Adenosine receptor A1 | 3 |
| 19072055 | 10.1021/jm800961g | Adenosine receptor A2b | 3 |
Data from ChEMBL 36 via Core Engine